Eric Lefkofsky the chief executive of Tempus most recently collaborated with the University of Chicago to utilize the data from the genome sequence and machine familiarization from Tempus. The aim of this was to equip the doctors with customized data that will ultimately aid the doctors to cater to the patients adequately. The treatment is modified for breast cancer patients and the data is provided through molecular analysis and sequencing.
Mr Eric is an astute entrepreneur situated in the US. He has an unwavering commitment to the cause of making cancer extinct. He also holds an executive position in several other successful conglomerates including Uptake Technologies, Echo Global Logistics, Lightbank, InnerWorkings, Groupon, and Mediaocean. Eric Lefkofsky also serves the Steppenwolf Theatre Company as the Chairman of the panel of Trustees. He is also a Trustee of the Lurie Children’s Hospital of Chicago.
Tempus is integral to the collection and analysis of data on up to 1000 cancer patient due to the fact that there is little to no access to information on the people who have suffered under the disease. This is an alarming statistic because breast cancer is one of the widely spread forms of cancer and lack of the data translates to the doctors giving treatment without the aid of patient information. The impact that Tempus makes to this is that this data they collect will be sufficient in enhancing the treatment development project. Click here to know more.
The initiative that has been undertaken by Tempus will propel the creation of one of the broadest clinically based database. Tempus has combined efforts with the Mayo Clinic, University of Michigan and the Rush University Medical Center among others
Eric Lefkofsky founded the Lefkofsky Family Foundation as part of his philanthropic ventures to help bring about dynamic changes to people it assists.